SCHEMBL30689312

SCHEMBL30689312

C=C(Cc1nc(-c2ccc(Oc3ccc(Cl)cn3)cc2)no1)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ FPR2 P25090 1/20 0.43
▸ SCN9A Q15858 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ TSHR P16473 3/20 0.42
▸ GSTP1 P09211 4/20 0.41
▸ FFAR1 O14842 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ LTA4H P09960 2/20 0.40
▸ SIRT2 Q8IXJ6 1/20 0.40
▸ ALOX15 P16050 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ LIPE Q05469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25801756 0.86 TSHR (0.55) MAPTTSHRGSTP1SMN1; SMN2SIRT2
SCHEMBL30689348 0.85 IP6K1 (0.41) TSHRGSTP1
SCHEMBL27291368 0.80 ACACB (0.39) MAPTGSTP1SMN1; SMN2
SCHEMBL23588077 0.80 ACACB (0.52) MAPTFFAR1SMN1; SMN2
SCHEMBL25802137 0.79 MAPT (0.50) MAPTTSHRFFAR1SMN1; SMN2MAPK1
SCHEMBL30006188 0.78 LTA4H (0.46) FPR2SCN9AMAPTTSHRFFAR1
SCHEMBL27204735 0.78 LTA4H (0.42) FPR2SCN9AMAPTTSHRFFAR1
SCHEMBL24664144 0.78 LTA4H (0.46) FPR2SCN9AMAPTTSHRFFAR1
SCHEMBL27171401 0.78 LTA4H (0.42) FPR2SCN9AMAPTTSHRFFAR1
SCHEMBL25802130 0.78 TP53 (0.42) MAPTTSHRSMN1; SMN2SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback